Daling Janet R, Doody David R, Sun Xiaofei, Trabert Britton L, Weiss Noel S, Chen Chu, Biggs Mary L, Starr Jacqueline R, Dey Sudhansu K, Schwartz Stephen M
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
Cancer. 2009 Mar 15;115(6):1215-23. doi: 10.1002/cncr.24159.
The incidence of testicular germ cell tumors (TGCTs) has been increasing the past 4 to 6 decades; however, exposures that account for this rise have not been identified. Marijuana use also grew during the same period, and it has been established that chronic marijuana use produces adverse effects on the human endocrine and reproductive systems. In this study, the authors tested the hypothesis that marijuana use is a risk factor for TGCT.
A population-based, case-control study of 369 men ages 18 to 44 years who were diagnosed with TGCT from January 1999 through January 2006 was conducted in King, Pierce and Snohomish Counties in Washington State. The responses of these men to questions on their lifetime marijuana use were compared with the responses of 979 age-matched controls who resided in the same 3 counties during the case diagnosis period.
Men with a TGCT were more likely to be current marijuana smokers at the reference date compared with controls (odds ratio [OR], 1.7; 95% confidence interval [95% CI], 1.1-2.5). In analyses according to histologic type, most of the association between current marijuana use and TGCT was observed in men who had nonseminomas/mixed histology tumors (current use: OR, 2.3; 95% CI, 1.3-4.0). Age at first use among current users (age<18 years [OR, 2.8] vs age>or=18 years [OR, 1.3]) and frequency of use (daily or weekly [OR, 3.0] vs less than once per week [OR, 1.8]) appeared to modify the risk.
An association was observed between marijuana use and the occurrence of nonseminoma TGCTs. Additional studies of TGCTs will be needed to test this hypothesis, including molecular analyses of cannabinoid receptors and endocannabinoid signaling, which may provide clues regarding the biologic mechanisms of TGCTs.
在过去4至6十年间,睾丸生殖细胞肿瘤(TGCT)的发病率一直在上升;然而,导致这种上升的暴露因素尚未明确。同期大麻使用也有所增加,并且已经证实长期使用大麻会对人类内分泌和生殖系统产生不良影响。在本研究中,作者检验了大麻使用是TGCT的一个危险因素这一假设。
在华盛顿州的金县、皮尔斯县和斯诺霍米什县开展了一项基于人群的病例对照研究,研究对象为1999年1月至2006年1月期间确诊为TGCT的369名年龄在18至44岁的男性。将这些男性对其终生大麻使用问题的回答与979名年龄匹配的对照者的回答进行比较,这些对照者在病例诊断期间居住在相同的3个县。
与对照者相比,在参考日期时患有TGCT的男性更有可能是当前大麻吸烟者(优势比[OR],1.7;95%置信区间[95%CI],1.1 - 2.5)。在根据组织学类型进行的分析中,当前大麻使用与TGCT之间的关联在患有非精原细胞瘤/混合组织学肿瘤的男性中最为明显(当前使用:OR,2.3;95%CI,1.3 - 4.0)。当前使用者的首次使用年龄(年龄<18岁[OR,2.8]与年龄≥18岁[OR,1.3])和使用频率(每天或每周[OR,3.0]与每周少于一次[OR,1.8])似乎会改变风险。
观察到大麻使用与非精原细胞瘤TGCT的发生之间存在关联。需要对TGCT进行更多研究来检验这一假设,包括对大麻素受体和内源性大麻素信号传导的分子分析,这可能为TGCT的生物学机制提供线索。